Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic.<\/p>\n
U\u011fur \u015eahin and \u00d6zlem T\u00fcreci, who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine, said they had made breakthroughs that fuelled their optimism for cancer vaccines in the coming years.<\/p>\n
Speaking on the BBC\u2019s Sunday with Laura Kuenssberg, Prof T\u00fcreci described how the mRNA technology at the heart of BioNTech\u2019s Covid vaccine could be repurposed so that it primed the immune system to attack cancer cells instead of invading coronaviruses.<\/p>\n
Read it all<\/a>.<\/p>\n Vaccines to treat #cancer<\/a> possible by 2030, say #BioNTech<\/a> founders. <\/p>\n U\u011fur \u015eahin n \u00d6zlem T\u00fcreci say mRNA Covid vaccine tech could be repurposed to help destroy cancer cells. (They, w\/ Pfizer, earlier created revolutionary mRNA #CovidVaccine<\/a>)#VaccinesWork<\/a>https:\/\/t.co\/srywPDHjKt<\/a><\/p>\n — Samir Kalia (@samir_kalia) October 17, 2022<\/a><\/p><\/blockquote>\n \n